Skip to main content

Table 1

From: Serial monitoring of LV function following chemotherapy: assessment using advanced echocardiography and cardiovascular magnetic resonance

 

LVEF (CMR)

(%)

LVEF

(Echo)

(%)

GLS

Baseline

71.9 ± 6.3

63.8 ± 5.7

-21.4 ± 2.6

3 months

66.7 ± 6.7 **

63.5 ± 7.2

-19.5 ± 2.0 **

12 months

65.9 ± 7.0 **

62.1 ± .9

-20.1 ± 2.6